1 active not recruiting, 1 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Zwi Berneman: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission DC vaccine - Acute Myeloid Leukemia | Phase 2 | Active not recruiting | Zwi Berneman | 130 | 2012-10-01 | 2024-03-12 |
| Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma dendritic cell vaccination (active specific immunotherapy) - Acute Myeloid Leukemia, Chronic Myeloid Leukemia | Phase 2 | Completed | Zwi Berneman | 38 | 2010-01-01 | 2024-12-13 |
Leukemia, Myeloid, Acute (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Multiple Myeloma (1) · Pathologic Complete Response (1)
lentiviral minigene vaccine of COVID-19 coronavirus (1)
Belgium (2)
Ann Van de Velde, MD, PhD (1) · Evelien LJ Smits, MSc, PhD (1)